Replies to post #32822 on Cel Sci Corporation (CVM)

[Fosco1]

@GD and Sab

I have read many explanations, but no satisfactory one, explaining why they would do so (wait for complete analysis rather than publish early results such as primary endpoint).

So my own explaination is that :

- In case primary endpoint is reached, I believe Geert will jump to the PR machine straight away. He won't be able to keep it to himself, and in anyway it will be good for the pps, and those who have expiring warrants and option calls will worship him for such announcement ! nobody will blame him for early divulgation

- In case primary endpoint is not reached, Geert will wait till the complete analysis is finalized, there might be some good news on the secondary endpoint sides.

His lawyer's wording is a precautionary measure in case some would be tempted to accuse him of non disclosing promised results. In the meantime,we will have no news for datalock as I was expecting (it might already have happened... or not)

JMO

Fosco

[GD]

In my 30 years of following biotech PIII results, I have
never heard any small biotech company releasing complete
PIII data in the first PR, win or failure, never, always
topline first and complete data at medical conferences.
Now you know why this information rings alarm bell in my
head, this is my opinion only, I may be 100% wrong on this,
but I am going to follow my instincts on CVM from now
on.